Lipoprotein(a) particle concentration and lipoprotein(a) cholesterol assays yield discordant classification of patients into four physiologically discrete groups

Journal of Clinical Lipidology

Volumn 6, Issue 4, 2012, Pages 368-373

  Konerman, Matthew ^a   Kulkarni, Krishnaji ^b   Toth, Peter P ^c,d   Jones, Steven R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Atherotech Diagnostics Inc   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d Sterling Rock Falls Clinic ^*  (United States)

Author keywords

HDL; LDL; Lipoprotein(a); Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PATIENT CODING; PRIORITY JOURNAL; PROTEIN DETERMINATION;

AGED; AZETIDINES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DYSLIPIDEMIAS; FATTY ACIDS, OMEGA-3; FIBRIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPOPROTEIN(A); MIDDLE AGED; NIACIN; PERIPHERAL ARTERIAL DISEASE; RETROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 84864283208     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2012.01.004     Document Type: Article

References (30)

1. E.J. Schaefer, M.E. Herman, J.J. Jenner, and L.J. Seman Lipoprotein(a): a pleotropic risk factor for cardiovascular disease P.O. Kwiterovich Jr. The Johns Hopkins Textbook of Dyslipidemia 2010 Lippincott Williams & Wilkins Philadelphia 222 229
2. R. Clarke, J.F. Peden, and J.C. Hopewell Genetic variants associated with Lp(a) lipoprotein level and coronary disease N Engl J Med 361 2009 2518 2528
3. J. Genest Jr., J.L. Jenner, and J.R. McNamara Prevalence of lipoprotein(a) [Lp(a)] excess in coronary artery disease Am J Cardiol 67 1991 1039 1145
4. M.L. Koschinsky, and S.M. Marcovina Lipoprotein(a) C.M. Ballantyne, Clinical Lipidology: a Companion to Braunwald's Heart Disease 2009 Saunders Elsevier Philadelphia 130 143
5. F. Kronenberg, M.F. Kronenberg, and S. Kiechl Role of lipoprotein (a) and apolipoprotein(a) phenotype in atherogenesis. Prospective results from the Bruneck study Circulation 100 1999 1154 1160 (Pubitemid 29426589)
6. 2 activity, and 10-year cardiovascular outcome. Prospective results from the Bruneck study Arterioscler Thromb Vasc Biol 27 2007 1788 1795 (Pubitemid 47207175)
7. S. Tsimikas, E.S. Brilakis, and E.R. Miller Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease N Engl J Med 353 2005 46 57 (Pubitemid 41007806)
8. P.R. Kamstrup, A. Tybjaerg-Hansen, R. Steffensen, and B.G. Nordestgaard Genetically elevated lipoprotein(a) and increased risk of myocardial infarction JAMA 301 2009 2331 2339
9. F. Paultre, T.A. Pearson, and H. Weil High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African-American and White men Arterioscler Thromb Vasc Biol 20 2000 2619 2624
10. 2 in atherosclerosis and cardiovascular disease Arterioscler Thromb Vasc Biol 27 2007 2094 2099 (Pubitemid 350287235)
11. L.J. Seman, C. DeLuca, and J.L. Jenner Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study Clin Chem 45 1999 1039 1046 (Pubitemid 29340541)
12. N. Rifai, J. Ma, and F.M. Sacks Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: the physicians' health study Clin Chem 50 2004 1364 1371 (Pubitemid 38970643)
13. S.M. Marcovina, J.J. Albers, and A.M. Scanu Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a) Clin Chem 46 2000 1956 1967
14. S.M. Marcovina, M.L. Koschinsky, J.J. Albers, and S. Skarlatos Report of the National Heart, Lung, and Blood Institute workshop on lipoprotein(a) and cardiovascular disease: recent advances and future directions Clin Chem 49 2003 1785 1796 (Pubitemid 37340313)
15. F. Dati, J.R. Tate, S.M. Marcovina, and A. Steinmetz First WHO/IFCC international reference reagent for lipoprotein(a) for immunoassay-Lp(a) SRM 2B Clin Chem Lab Med 42 2004 670 676 (Pubitemid 38979146)
16. K.R. Kulkarni, D.W. Garber, S.M. Marcovina, and J.P. Segrest Quantification of cholesterol in all lipoprotein classes by the VAP-II method J Lipid Res 35 1994 159 168 (Pubitemid 24028002)
17. E.J. Jeyarajah, W.C. Cromwell, and J.D. Otvos Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy Clin Lab Med 26 2006 847 870 (Pubitemid 44716510)
18. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
19. J.W. Gaubatz, R.C. Hoogeveen, and A.S. Hoffman Isolation, quantitation, and characterization of a stable complex formed by Lp(a) binding to triglyceride-rich lipoproteins J Lipid Res 42 2001 2058 2068 (Pubitemid 34001055)
20. T.P. Bersot, T.L. Innerarity, and R.E. Pitas Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein(a) and that cause lipid accumulation in macrophages J Clin Invest 77 1986 622 630 (Pubitemid 16037665)
21. J.P. Werba, O. Safa, and G. Gianfranceschi Plasma triglycerides and lipoprotein(a): inverse relationship in a hyperlipidemic Italian population Atherosclerosis 101 1993 203 211 (Pubitemid 23214233)
22. W.J. McConathy, V.N. Trieu, E. Koren, C.S. Wang, and C.C. Corder Triglyceride-rich lipoprotein interactions with Lp(a) Chem Phys Lipids 67 1994 105 113 (Pubitemid 24054467)
23. J.S. Cohn, C.W. Lam, D.R. Sullivan, and W.J. Hensley Plasma lipoprotein distribution of apolipoprotein(a) in the fed and fasted states Atherosclerosis 90 1991 59 66
24. W. Bartens, D.J. Rader, G. Talley, and H.B. Brewer Jr. Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia Atherosclerosis 108 1994 149 157 (Pubitemid 24265887)
25. F. Nassir, D.K. Bonen, and N.O. Davidson Apolipoprotein(a) synthesis and secretion from hepatoma cells is coupled to triglyceride synthesis and secretion J Biol Chem 273 1998 17793 17800 (Pubitemid 28355123)
26. K.M. Argraves, K.F. Kozarsky, J.T. Fallon, P.C. Harpel, and D.K. Strickland The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor J Clin Invest 100 1997 2170 2181 (Pubitemid 27500138)
27. B. Philips, and A.M. Scanu Viewing the cardiovascular pathogenicity of Lp(a) from the pro-inflammatory side Vasc Dis Prev 5 2008 150 155
28. C. Edelstein, D. Pfaffinger, and J. Hinman Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a) J Biol Chem 278 2003 52841 52847 (Pubitemid 38035883)
29. S. Tsimikas, and J.L. Witztum The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity Curr Opin Lipidol 19 2008 369 377
30. S. Lamon-Fava, S.M. Marcovina, and J.J. Albers Lipoprotein(a) levels, apolipoprotein(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study J Lipid Res 52 2011 1181 1187